Kitazato (368A) Q2 2026 earnings summary

Executive summary

• Net sales for Q2 FY2026 reached 5,247 million yen, up 8.3% year-over-year, driven by strong domestic and overseas demand, especially in Europe, the US, and India.

• Interim net income was 1,804 million yen, a 6.0% increase year-over-year, and operating profit rose 5.9% to 2,769 million yen.

• The company maintained a stable supply of cryopreservation-related products and expanded regulatory approvals and distributor networks overseas.

• New and improved products, particularly in media and medical devices, contributed to strong performance.

• Progress toward full-year targets is on track, with all major profit metrics exceeding 49% of annual forecasts.

Financial highlights

• Operating profit for Q2 FY2026 was 2,769 million yen (+5.9% YoY), with an operating margin of 52.8%.

• Ordinary profit reached 2,728 million yen (+4.9% YoY), and interim net income margin was 34.4%.

• Gross profit increased by 240 million yen year-over-year, reaching 3,462 million yen, despite a higher cost of sales ratio.

• Equity ratio improved to 92.6%, with total assets at 19,895 million yen and net assets at 18,414 million yen.

• Cash and cash equivalents at the end of the interim period were 11,608 million yen.

Outlook and guidance

• Full-year FY2026 forecast remains unchanged: net sales of 10,602 million yen (+2.9% YoY), operating profit of 5,374 million yen, and net income of 3,498 million yen.

• The company continues to invest in overseas expansion, production optimization, and automation, while monitoring international market uncertainties.

• Most overseas transactions are in yen, limiting FX impact.